Cutting-Edge Oxygen Technology for Gum Disease and Dental Implants
Gum disease and peri-implantitis are common dental issues that can lead to tooth and implant loss. Traditional treatments may not be enough to stop inflammation and promote tissue regeneration. Horch (2018) introduces an innovative non-antibiotic approach utilizing active oxygen technology known as OXYSAFE® from Ardoz Healthcare International.
How Active Oxygen Works
OXYSAFE® releases oxygen upon contact with the oral mucosa, targeting and inactivating harmful bacteria within biofilms without disrupting the oral flora or causing resistance.
Clinical Benefits and Scientific Support
Studies show reduced pocket depth, inflammation, and improved gum health with OXYSAFE®. Research from institutions like Radboud University Nijmegen demonstrates a significant decrease in pathogenic bacteria and up to 56% reduction in pocket depth. The technology also promotes partial re-osseointegration in 75% of peri-implantitis cases, even in high-risk patients like smokers.
Biocompatibility and Patient Safety
OXYSAFE® is biocompatible, non-cytotoxic, and safe for all phases of gum and implant therapy without affecting blood cells or bone cells.
Dual Treatment Approach
The protocol involves professional application of OXYSAFE® Perio Protection Gel by the dentist followed by at-home use of OXYSAFE® Liquid Mouthwash, ensuring long-term gum health stability and reducing infections.
Modern Dentistry Relevance
OXYSAFE® aligns with the demand for minimally invasive, evidence-based, and antibiotic-sparing therapies in dentistry, offering a scientifically supported alternative with both clinical effectiveness and patient safety.
For more information on cutting-edge dental solutions, visit Ardoz.com for resources and technology to enhance oral care practices.